About

EMDrugs is an educational pharmacology reference for healthcare professionals and trainees involved in emergency care.

• Founded in 2021, EMDrugs was created and is maintained by emergency physicians as a specialized pharmacology resource.

• Content is developed through independent reviews of current medical literature and evidence-based medicine principles, integrated with the real-world clinical experience of emergency physicians.

• Scientific and pharmacological information is written and edited by specialist emergency physicians, in collaboration with other healthcare professionals.

• EMDrugs is intended for educational and informational purposes only and does not constitute medical advice.

What you will find

• Induction agents and neuromuscular blocking agents
• Pain pharmacotherapy
• Vasopressors
• Fibrinolytic therapy
• Antiepileptic drugs, and more

Membership and pricing

Full access is available through annual subscriptions:

• Physician: US$48/year
• Healthcare Professional (non-physician): US$36/year
• Trainee: US$24/year

All plans include the same full access to EMDrugs. Subscriptions renew annually unless canceled. Access remains available through the end of the paid billing period.

Content integrity and AI use

All scientific and pharmacological content is written and reviewed by licensed physicians based on independent reviews of the medical literature.

AI and language model tools may be used to support literature analysis, summarize information, and optimize EN/ES translations.

• Translations are reviewed and edited by native or proficient English and Spanish speakers.
• All scientific content remains subject to physician review and editorial oversight.

Get started

Register for free and explore our open-access content, including: